Highlight Investment Research is an independent and privately owned organization, has come a long way and today has emerged as a premium Indian stock & commodities consultancy, with an absolute focus on business and a commitment to provide “Real value for money to all its clients”.
Sun Pharma gave clarification on Mohali facility inspection saying that the plant is undergoing inspection by USFDA, which was started on Sept 10.
Wipro joins Duck Creek Technologies' Alliance Program.
Godrej Agrovet is planning to merge its subsidiary Astec LifeSciences with self on Sept 14.
Redington (India) to consider share buyback on Sept 17.
Cipla gets consent for its HIV treatment combination medicine ‘TLD’ from the South African Health Products Regulatory Authority.
TRAI slapped penalties totaling to Rs34lakh and Rs11lakh on Reliance Industries’ Reliance Jio and Bharti Airtel, for not meeting certain call centre service parameters.
HCL Tech's Rs4,000cr buyback offer will be commenced on September 18
Alembic received an approval from board for demerging Identified Real Estate Undertaking of the Company into Shreno Limited.
Biocon and Biocon Research reduced stake in Syngene International by 0.50% to 70.24% after selling shares of the company through open market on September 11.
NTPC clarified that the company is considering an investment approval for Talcher plant expansion.
Narayana Hrudayalaya’s subsidiary inked pact with Imperial Hospital to operate and manage the latter’s cardiac services department in Bangladesh.
Ajanta Pharma gets an approval from USFDA nod for Fenofibrate oral capsule.
No comments